The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease
Clinical trial NCT03829046 · COMPLETED
Trial details
- NCT number
- NCT03829046
- Sponsor
- Robert Rosenson
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-03
- Primary completion
- 2021-11-15
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.